|Bid||6.15 x 3100|
|Ask||6.16 x 2900|
|Day's range||5.99 - 6.33|
|52-week range||0.47 - 15.69|
|Beta (5Y monthly)||1.99|
|PE ratio (TTM)||N/A|
|Earnings date||13 May 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||11.50|
Bionano Genomics (BNGO) is likely to provide updates on earnings and revenues when it reports second-quarter 2021 results.
In the latest trading session, Bionano Genomics, Inc. (BNGO) closed at $5.87, marking a -1.68% move from the previous day.
The market's pessimism about these diagnostics stocks appeared unrelated to company-specific news.